Kifayat Ullah Shah | Pharmaceutics | Best Researcher Award Posted on 09/09/202410/09/2024 by ScienceFather Dr. Kifayat Ullah Shah | Pharmaceutics | Best Researcher Award Associate Professor at Quaid-i-Azam University, Pakistan Dr. Kifayat Ullah Shah is an accomplished academic and researcher in the field of pharmaceutical sciences, currently serving as an Associate Professor at Quaid-e-Azam University in Islamabad since September 2014. He previously held positions as an Assistant Professor at Hamdard University and a Teaching Assistant at Gomal University. Dr. Shah earned his Ph.D. in Pharmaceutics from Gomal University, where he also completed his Bachelor of Pharmacy. His research interests include the formulation and development of pharmaceuticals, controlled drug delivery, and nanotechnology applications in drug delivery. He has authored several publications with significant impact, reflecting his contributions to the field, and has supervised over 35 MPhil and five PhD students. Dr. Shah has received grants for various research projects, showcasing his commitment to advancing pharmaceutical sciences. Additionally, he is actively involved in academic administration and quality assurance within higher education. Profile Scopus Profile Google Scholar Profile ORCID Profile Education Dr. Kifayat Ullah Shah holds an impressive educational background in pharmaceutical sciences. He earned his Doctor of Philosophy (Ph.D.) in Pharmaceutics from Gomal University, Dera Ismāīl Khān, Khyber Pakhtunkhwa, Pakistan, between 2008 and 2014. Prior to that, he obtained a Bachelor of Pharmacy (B.Pharmacy) degree from the same institution, Gomal University, from 2002 to 2006. His early education includes a Pre-Medical F.Sc. from Govt. P.G. College Bannu in 2000-2001 and Matriculation in Science from Govt. High School-02 Bannu in 1998-1999. This strong academic foundation has equipped Dr. Shah with the knowledge and skills necessary to excel in both research and teaching within the field of pharmaceutical sciences. Professional Experience Dr. Kifayat Ullah Shah has extensive professional experience in academia and the pharmaceutical industry. He has served as an Associate Professor at Quaid-e-Azam University, Islamabad, since September 2014, where he has contributed to teaching and research in pharmaceutical sciences. Prior to this role, Dr. Shah was an Assistant Professor at Hamdard University from January to August 2014 and worked as a Teaching Assistant at Gomal University for a brief period in late 2011. His early career included experience as a Production Pharmacist at Glitz Pharmaceuticals in Islamabad, where he gained practical insights into pharmaceutical production and formulation. Dr. Shah’s diverse professional background, coupled with his research focus on drug delivery systems and nanotechnology, has positioned him as a prominent figure in his field. Research Interest Dr. Kifayat Ullah Shah’s research interests are centered around the formulation and development of pharmaceutical products, with a particular focus on controlled drug delivery systems. His expertise encompasses a variety of advanced techniques, including microencapsulation, nanotechnology, and thermal analysis, which he applies to improve the efficacy and safety of drug formulations. Dr. Shah has conducted significant research on targeted drug delivery mechanisms, exploring innovative methods to enhance therapeutic outcomes for various medical conditions. His work also includes the design, preparation, and evaluation of controlled release polymeric formulations, aiming to investigate drug release patterns and mechanisms. Through his research, Dr. Shah seeks to contribute to the advancement of pharmaceutical sciences and improve patient care through effective drug delivery systems. Research Skills Dr. Kifayat Ullah Shah possesses a robust skill set in pharmaceutical research, particularly in the formulation and development of drug delivery systems. His expertise includes advanced techniques such as microencapsulation, controlled drug delivery, and targeted drug delivery, which are essential for optimizing the therapeutic effects of pharmaceuticals. Dr. Shah is proficient in utilizing various analytical instruments, including UV/Visible spectrophotometry, differential scanning calorimetry (DSC), and thermal analysis, to evaluate and characterize pharmaceutical formulations. His research skills also extend to pre-formulation studies and the application of nanotechnology in drug delivery, enabling him to design innovative solutions for complex pharmaceutical challenges. Through his comprehensive knowledge and practical experience, Dr. Shah effectively contributes to the advancement of pharmaceutical sciences and the development of new therapeutic strategies. Award and Recognition Dr. Kifayat Ullah Shah has garnered several awards and recognitions throughout his career, highlighting his significant contributions to the field of pharmaceutics. He successfully obtained funding for key research projects, including a grant of 0.5 million PKR from the Higher Education Commission (HEC) of Pakistan for the fabrication, characterization, and in vitro evaluation of finasteride nanoparticles. Additionally, he received a substantial grant of 4.5 million PKR for his project on silica-based nanoparticles as hemostatic agents for controlling internal bleeding. Dr. Shah has also been recognized for his academic excellence, having supervised over 35 MPhil and five PhD students, and for his impactful research publications, which have contributed to advancements in drug delivery systems. His work has earned him respect and acknowledgment in the academic and research communities, reflecting his dedication to enhancing pharmaceutical sciences and improving patient care. Conclusion Dr. Kifayat Ullah Shah’s impressive academic credentials, extensive research experience, impactful publications, successful funding acquisitions, and contributions to education and administrative services strongly position him as a deserving candidate for the Research for Best Researcher Award. His ongoing commitment to advancing pharmaceutical sciences through research and mentorship further strengthens his suitability for this recognition. Publication Top Notes “Non-pharmacological management of hypertension: in the light of current research” Journal: Irish Journal of Medical Science (1971-) Cited by: 180 Year: 2019 Volume: 188 Pages: 437-452 “From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)” Journal: Expert Opinion on Drug Delivery Cited by: 148 Year: 2017 Volume: 14, Issue 11 Pages: 1325-1340 “Proniosomes derived niosomes: recent advancements in drug delivery and targeting” Journal: Drug Delivery Cited by: 121 Year: 2017 Volume: 24, Issue 2 Pages: 56-69 “A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers” Journal: Carbohydrate Polymers Cited by: 106 Year: 2020 Volume: 250 Pages: 116800 “Elemental analysis of some medicinal plants used in traditional medicine by atomic absorption spectrophotometer (AAS)” Journal: Journal of Medicinal Plants Research Cited by: 93 Year: 2010 Volume: 4, Issue 19 Pages: 1987-1990 “Polymeric nanogels as versatile nanoplatforms for biomedical applications” Journal: Journal of Nanomaterials Cited by: 81 Year: 2019 Volume: 2019, Issue 1 Pages: 1526186 “Hemostatic strategies for uncontrolled bleeding: A comprehensive update” Journal: Journal of Biomedical Materials Research Part B: Applied Biomaterials Cited by: 73 Year: 2021 Volume: 109 “Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product” Journal: Journal of Drug Delivery Science and Technology Cited by: 72 Year: 2019 Volume: 51 Pages: 583-590 “Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta-analysis” Journal: International Journal of Clinical Pharmacy Cited by: 56 Year: 2021 Volume: 43 Pages: 486-501 “Co-delivery strategies to overcome multidrug resistance in ovarian cancer” Journal: International Journal of Pharmaceutics Cited by: 47 Year: 2017 Volume: 533, Issue 1 Pages: 111-124 “Regulating drug release behavior and kinetics from matrix tablets based on fine particle‐sized ethyl cellulose ether derivatives: An in vitro and in vivo evaluation” Journal: The Scientific World Journal Cited by: 46 Year: 2012 Volume: 2012, Issue 1 Pages: 842348
Dr. Kifayat Ullah Shah is an accomplished academic and researcher in the field of pharmaceutical sciences, currently serving as an Associate Professor at Quaid-e-Azam University in Islamabad since September 2014. He previously held positions as an Assistant Professor at Hamdard University and a Teaching Assistant at Gomal University. Dr. Shah earned his Ph.D. in Pharmaceutics from Gomal University, where he also completed his Bachelor of Pharmacy. His research interests include the formulation and development of pharmaceuticals, controlled drug delivery, and nanotechnology applications in drug delivery. He has authored several publications with significant impact, reflecting his contributions to the field, and has supervised over 35 MPhil and five PhD students. Dr. Shah has received grants for various research projects, showcasing his commitment to advancing pharmaceutical sciences. Additionally, he is actively involved in academic administration and quality assurance within higher education. Profile Scopus Profile Google Scholar Profile ORCID Profile Education Dr. Kifayat Ullah Shah holds an impressive educational background in pharmaceutical sciences. He earned his Doctor of Philosophy (Ph.D.) in Pharmaceutics from Gomal University, Dera Ismāīl Khān, Khyber Pakhtunkhwa, Pakistan, between 2008 and 2014. Prior to that, he obtained a Bachelor of Pharmacy (B.Pharmacy) degree from the same institution, Gomal University, from 2002 to 2006. His early education includes a Pre-Medical F.Sc. from Govt. P.G. College Bannu in 2000-2001 and Matriculation in Science from Govt. High School-02 Bannu in 1998-1999. This strong academic foundation has equipped Dr. Shah with the knowledge and skills necessary to excel in both research and teaching within the field of pharmaceutical sciences. Professional Experience Dr. Kifayat Ullah Shah has extensive professional experience in academia and the pharmaceutical industry. He has served as an Associate Professor at Quaid-e-Azam University, Islamabad, since September 2014, where he has contributed to teaching and research in pharmaceutical sciences. Prior to this role, Dr. Shah was an Assistant Professor at Hamdard University from January to August 2014 and worked as a Teaching Assistant at Gomal University for a brief period in late 2011. His early career included experience as a Production Pharmacist at Glitz Pharmaceuticals in Islamabad, where he gained practical insights into pharmaceutical production and formulation. Dr. Shah’s diverse professional background, coupled with his research focus on drug delivery systems and nanotechnology, has positioned him as a prominent figure in his field. Research Interest Dr. Kifayat Ullah Shah’s research interests are centered around the formulation and development of pharmaceutical products, with a particular focus on controlled drug delivery systems. His expertise encompasses a variety of advanced techniques, including microencapsulation, nanotechnology, and thermal analysis, which he applies to improve the efficacy and safety of drug formulations. Dr. Shah has conducted significant research on targeted drug delivery mechanisms, exploring innovative methods to enhance therapeutic outcomes for various medical conditions. His work also includes the design, preparation, and evaluation of controlled release polymeric formulations, aiming to investigate drug release patterns and mechanisms. Through his research, Dr. Shah seeks to contribute to the advancement of pharmaceutical sciences and improve patient care through effective drug delivery systems. Research Skills Dr. Kifayat Ullah Shah possesses a robust skill set in pharmaceutical research, particularly in the formulation and development of drug delivery systems. His expertise includes advanced techniques such as microencapsulation, controlled drug delivery, and targeted drug delivery, which are essential for optimizing the therapeutic effects of pharmaceuticals. Dr. Shah is proficient in utilizing various analytical instruments, including UV/Visible spectrophotometry, differential scanning calorimetry (DSC), and thermal analysis, to evaluate and characterize pharmaceutical formulations. His research skills also extend to pre-formulation studies and the application of nanotechnology in drug delivery, enabling him to design innovative solutions for complex pharmaceutical challenges. Through his comprehensive knowledge and practical experience, Dr. Shah effectively contributes to the advancement of pharmaceutical sciences and the development of new therapeutic strategies. Award and Recognition Dr. Kifayat Ullah Shah has garnered several awards and recognitions throughout his career, highlighting his significant contributions to the field of pharmaceutics. He successfully obtained funding for key research projects, including a grant of 0.5 million PKR from the Higher Education Commission (HEC) of Pakistan for the fabrication, characterization, and in vitro evaluation of finasteride nanoparticles. Additionally, he received a substantial grant of 4.5 million PKR for his project on silica-based nanoparticles as hemostatic agents for controlling internal bleeding. Dr. Shah has also been recognized for his academic excellence, having supervised over 35 MPhil and five PhD students, and for his impactful research publications, which have contributed to advancements in drug delivery systems. His work has earned him respect and acknowledgment in the academic and research communities, reflecting his dedication to enhancing pharmaceutical sciences and improving patient care. Conclusion Dr. Kifayat Ullah Shah’s impressive academic credentials, extensive research experience, impactful publications, successful funding acquisitions, and contributions to education and administrative services strongly position him as a deserving candidate for the Research for Best Researcher Award. His ongoing commitment to advancing pharmaceutical sciences through research and mentorship further strengthens his suitability for this recognition. Publication Top Notes “Non-pharmacological management of hypertension: in the light of current research” Journal: Irish Journal of Medical Science (1971-) Cited by: 180 Year: 2019 Volume: 188 Pages: 437-452 “From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)” Journal: Expert Opinion on Drug Delivery Cited by: 148 Year: 2017 Volume: 14, Issue 11 Pages: 1325-1340 “Proniosomes derived niosomes: recent advancements in drug delivery and targeting” Journal: Drug Delivery Cited by: 121 Year: 2017 Volume: 24, Issue 2 Pages: 56-69 “A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers” Journal: Carbohydrate Polymers Cited by: 106 Year: 2020 Volume: 250 Pages: 116800 “Elemental analysis of some medicinal plants used in traditional medicine by atomic absorption spectrophotometer (AAS)” Journal: Journal of Medicinal Plants Research Cited by: 93 Year: 2010 Volume: 4, Issue 19 Pages: 1987-1990 “Polymeric nanogels as versatile nanoplatforms for biomedical applications” Journal: Journal of Nanomaterials Cited by: 81 Year: 2019 Volume: 2019, Issue 1 Pages: 1526186 “Hemostatic strategies for uncontrolled bleeding: A comprehensive update” Journal: Journal of Biomedical Materials Research Part B: Applied Biomaterials Cited by: 73 Year: 2021 Volume: 109 “Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product” Journal: Journal of Drug Delivery Science and Technology Cited by: 72 Year: 2019 Volume: 51 Pages: 583-590 “Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta-analysis” Journal: International Journal of Clinical Pharmacy Cited by: 56 Year: 2021 Volume: 43 Pages: 486-501 “Co-delivery strategies to overcome multidrug resistance in ovarian cancer” Journal: International Journal of Pharmaceutics Cited by: 47 Year: 2017 Volume: 533, Issue 1 Pages: 111-124 “Regulating drug release behavior and kinetics from matrix tablets based on fine particle‐sized ethyl cellulose ether derivatives: An in vitro and in vivo evaluation” Journal: The Scientific World Journal Cited by: 46 Year: 2012 Volume: 2012, Issue 1 Pages: 842348
Dr. Kifayat Ullah Shah holds an impressive educational background in pharmaceutical sciences. He earned his Doctor of Philosophy (Ph.D.) in Pharmaceutics from Gomal University, Dera Ismāīl Khān, Khyber Pakhtunkhwa, Pakistan, between 2008 and 2014. Prior to that, he obtained a Bachelor of Pharmacy (B.Pharmacy) degree from the same institution, Gomal University, from 2002 to 2006. His early education includes a Pre-Medical F.Sc. from Govt. P.G. College Bannu in 2000-2001 and Matriculation in Science from Govt. High School-02 Bannu in 1998-1999. This strong academic foundation has equipped Dr. Shah with the knowledge and skills necessary to excel in both research and teaching within the field of pharmaceutical sciences.
Dr. Kifayat Ullah Shah has extensive professional experience in academia and the pharmaceutical industry. He has served as an Associate Professor at Quaid-e-Azam University, Islamabad, since September 2014, where he has contributed to teaching and research in pharmaceutical sciences. Prior to this role, Dr. Shah was an Assistant Professor at Hamdard University from January to August 2014 and worked as a Teaching Assistant at Gomal University for a brief period in late 2011. His early career included experience as a Production Pharmacist at Glitz Pharmaceuticals in Islamabad, where he gained practical insights into pharmaceutical production and formulation. Dr. Shah’s diverse professional background, coupled with his research focus on drug delivery systems and nanotechnology, has positioned him as a prominent figure in his field. Research Interest Dr. Kifayat Ullah Shah’s research interests are centered around the formulation and development of pharmaceutical products, with a particular focus on controlled drug delivery systems. His expertise encompasses a variety of advanced techniques, including microencapsulation, nanotechnology, and thermal analysis, which he applies to improve the efficacy and safety of drug formulations. Dr. Shah has conducted significant research on targeted drug delivery mechanisms, exploring innovative methods to enhance therapeutic outcomes for various medical conditions. His work also includes the design, preparation, and evaluation of controlled release polymeric formulations, aiming to investigate drug release patterns and mechanisms. Through his research, Dr. Shah seeks to contribute to the advancement of pharmaceutical sciences and improve patient care through effective drug delivery systems. Research Skills Dr. Kifayat Ullah Shah possesses a robust skill set in pharmaceutical research, particularly in the formulation and development of drug delivery systems. His expertise includes advanced techniques such as microencapsulation, controlled drug delivery, and targeted drug delivery, which are essential for optimizing the therapeutic effects of pharmaceuticals. Dr. Shah is proficient in utilizing various analytical instruments, including UV/Visible spectrophotometry, differential scanning calorimetry (DSC), and thermal analysis, to evaluate and characterize pharmaceutical formulations. His research skills also extend to pre-formulation studies and the application of nanotechnology in drug delivery, enabling him to design innovative solutions for complex pharmaceutical challenges. Through his comprehensive knowledge and practical experience, Dr. Shah effectively contributes to the advancement of pharmaceutical sciences and the development of new therapeutic strategies. Award and Recognition Dr. Kifayat Ullah Shah has garnered several awards and recognitions throughout his career, highlighting his significant contributions to the field of pharmaceutics. He successfully obtained funding for key research projects, including a grant of 0.5 million PKR from the Higher Education Commission (HEC) of Pakistan for the fabrication, characterization, and in vitro evaluation of finasteride nanoparticles. Additionally, he received a substantial grant of 4.5 million PKR for his project on silica-based nanoparticles as hemostatic agents for controlling internal bleeding. Dr. Shah has also been recognized for his academic excellence, having supervised over 35 MPhil and five PhD students, and for his impactful research publications, which have contributed to advancements in drug delivery systems. His work has earned him respect and acknowledgment in the academic and research communities, reflecting his dedication to enhancing pharmaceutical sciences and improving patient care. Conclusion Dr. Kifayat Ullah Shah’s impressive academic credentials, extensive research experience, impactful publications, successful funding acquisitions, and contributions to education and administrative services strongly position him as a deserving candidate for the Research for Best Researcher Award. His ongoing commitment to advancing pharmaceutical sciences through research and mentorship further strengthens his suitability for this recognition. Publication Top Notes “Non-pharmacological management of hypertension: in the light of current research” Journal: Irish Journal of Medical Science (1971-) Cited by: 180 Year: 2019 Volume: 188 Pages: 437-452 “From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)” Journal: Expert Opinion on Drug Delivery Cited by: 148 Year: 2017 Volume: 14, Issue 11 Pages: 1325-1340 “Proniosomes derived niosomes: recent advancements in drug delivery and targeting” Journal: Drug Delivery Cited by: 121 Year: 2017 Volume: 24, Issue 2 Pages: 56-69 “A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers” Journal: Carbohydrate Polymers Cited by: 106 Year: 2020 Volume: 250 Pages: 116800 “Elemental analysis of some medicinal plants used in traditional medicine by atomic absorption spectrophotometer (AAS)” Journal: Journal of Medicinal Plants Research Cited by: 93 Year: 2010 Volume: 4, Issue 19 Pages: 1987-1990 “Polymeric nanogels as versatile nanoplatforms for biomedical applications” Journal: Journal of Nanomaterials Cited by: 81 Year: 2019 Volume: 2019, Issue 1 Pages: 1526186 “Hemostatic strategies for uncontrolled bleeding: A comprehensive update” Journal: Journal of Biomedical Materials Research Part B: Applied Biomaterials Cited by: 73 Year: 2021 Volume: 109 “Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product” Journal: Journal of Drug Delivery Science and Technology Cited by: 72 Year: 2019 Volume: 51 Pages: 583-590 “Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta-analysis” Journal: International Journal of Clinical Pharmacy Cited by: 56 Year: 2021 Volume: 43 Pages: 486-501 “Co-delivery strategies to overcome multidrug resistance in ovarian cancer” Journal: International Journal of Pharmaceutics Cited by: 47 Year: 2017 Volume: 533, Issue 1 Pages: 111-124 “Regulating drug release behavior and kinetics from matrix tablets based on fine particle‐sized ethyl cellulose ether derivatives: An in vitro and in vivo evaluation” Journal: The Scientific World Journal Cited by: 46 Year: 2012 Volume: 2012, Issue 1 Pages: 842348
Taigang Liang | Drug Design | Best Researcher Award Posted on 19/07/202419/07/2024 by ScienceFather Prof. Taigang Liang | Drug Design | Best Researcher Award Professor at School of Pharmacy/Shanxi Medical University, China.